These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33073559)

  • 1. Adding 64Cu radiopharmaceuticals to the toolkit of molecular imaging.
    Capriotti G; Duatti A
    Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):327-328. PubMed ID: 33073559
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in copper radiopharmaceuticals.
    Hao G; Singh AN; Oz OK; Sun X
    Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncology PET radiopharmaceuticals in clinic and research in 2020].
    Mikecz P; Fekete A; Tóth G; Környei J; Bali T; Cservenyák T; Borbély K
    Magy Onkol; 2020 Jun; 64(2):104-111. PubMed ID: 32520003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
    Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
    Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhou Y; Li J; Xu X; Zhao M; Zhang B; Deng S; Wu Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830758. PubMed ID: 30764737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.
    Di Bartolo N; Sargeson AM; Smith SV
    Org Biomol Chem; 2006 Sep; 4(17):3350-7. PubMed ID: 17036125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.
    Willmann JK; Chen K; Wang H; Paulmurugan R; Rollins M; Cai W; Wang DS; Chen IY; Gheysens O; Rodriguez-Porcel M; Chen X; Gambhir SS
    Circulation; 2008 Feb; 117(7):915-22. PubMed ID: 18250264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PET radiopharmaceuticals: novelties and new possibilities].
    Környei J; Mikecz P; Tóth G
    Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging value of 64Cu for molecular imaging and therapy.
    Bolzati C; Duatti A
    Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):329-337. PubMed ID: 33026210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
    Deng H; Wang H; Wang M; Li Z; Wu Z
    Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice.
    Huda P; Binderup T; Pedersen MC; Midtgaard SR; Elema DR; Kjær A; Jensen M; Arleth L
    PLoS One; 2015; 10(7):e0129310. PubMed ID: 26132074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals.
    Liu S; Li Z; Yap LP; Huang CW; Park R; Conti PS
    Chemistry; 2011 Sep; 17(37):10222-5. PubMed ID: 21815227
    [No Abstract]   [Full Text] [Related]  

  • 15. New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection.
    Wiehr S; Warnke P; Rolle AM; Schütz M; Oberhettinger P; Kohlhofer U; Quintanilla-Martinez L; Maurer A; Thornton C; Boschetti F; Reischl G; Autenrieth IB; Pichler BJ; Autenrieth SE
    Oncotarget; 2016 Mar; 7(10):10990-1001. PubMed ID: 26934329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer.
    Gourni E; Del Pozzo L; Kheirallah E; Smerling C; Waser B; Reubi JC; Paterson BM; Donnelly PS; Meyer PT; Maecke HR
    Mol Pharm; 2015 Aug; 12(8):2781-90. PubMed ID: 26132879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of new tetradentate ligands with potential applications for 64Cu PET-imaging.
    Bodio E; Julienne K; Gouin SG; Faivre-Chauvet A; Deniaud D
    Bioorg Med Chem Lett; 2011 Feb; 21(3):924-7. PubMed ID: 21236669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of Prostate Cancer Using
    Singh A; Kulkarni HR; Baum RP
    PET Clin; 2017 Apr; 12(2):193-203. PubMed ID: 28267453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
    Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
    Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of image quality with 62Cu and 64Cu-labeled radiotracers in positron emission tomography whole-body phantom imaging.
    Kobayashi M; Mori T; Tsujikawa T; Ogai K; Sugama J; Kiyono Y; Kawai K; Okazawa H
    Hell J Nucl Med; 2015; 18(2):103-7. PubMed ID: 26187208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.